U.S. Stock News

Teledyne Technologies (TDY) has been busy. New contracts in European unmanned systems, fresh imaging hardware on European Space Agency missions, and a 3D Time-of-Flight camera launch are all nudging investors to reassess the stock. Recent contract wins and space imaging deployments sit against a mixed tape for Teledyne Technologies, with the share price at US$609.08 after a 1-day share price return of 0.93% and a 7-day share price return of 2.00%, yet down 4.26% over 30 days and slightly...

Interest rates keep climbing, borrowing costs for farmers are rising, and the old playbook for agricultural input and equipment stocks no longer looks so simple. That creates a window for investors willing to sort through who might handle tighter credit conditions better than peers. This article walks through three stocks from a Global Agricultural Input & Equipment Providers screener that appear positively exposed to the latest Federal Reserve move and explains why each one deserves a closer...

The St. Joe Company expanded its joint venture with Minto Communities USA for Latitude Margaritaville Watersound, planning a second phase with about 3,500 additional homes and more resort-style amenities. This brings the active adult community to roughly 7,200 planned homes with updated financial terms. This larger buildout concentrates St. Joe even more in active adult housing and resort-style services. It also ties the business closely to long-term demand for lifestyle communities in the...

Fresh sanctions that target buyers of Russian oil and those helping Moscow evade restrictions keep energy security and geopolitical risk in sharp focus. That prompts governments to prioritize air power, surveillance and missile defense. Investors looking at businesses tied to aircraft, satellites and military hardware may view this as a continuing spending theme. This article highlights three stocks from this aerospace and defense supply chain that may be worth a closer look. The three...

Lineage, Inc. previously declared a third quarter 2026 cash dividend of $0.5325 per share, payable on October 21, 2026, to shareholders of record as of September 30, 2026. This cash payout highlights how Lineage is balancing shareholder income demands with capital needs for its cold storage network, technology rollouts, and facility pipeline. We will now look at how Lineage's investment narrative could be affected by this Q3 cash dividend decision and payout commitment. Compare Lineage's...

Interest rates look set to stay higher for longer as the Fed keeps pushing back against inflation that is still above its 2% target, and that puts short term cash and Treasury investing firmly in the spotlight. Investors who usually ignore this corner of the market are starting to pay attention, because stronger yields on cash alternatives can shift how you think about risk across a whole portfolio. This article walks through three stocks from our US Short-Term Cash & Treasury Investment...

Anderon LLC finalized a $1b award under the CHIPS and Science Act, matched by IBM's own $1b commitment, to scale its 300-millimeter quantum wafer foundry in Albany, where initial superconducting qubit wafers are already running through production. The combination of federal funding and IBM's capital places quantum hardware manufacturing costs, supply resilience, and commercialization timelines squarely on the operational agenda for International Business Machines. This article examines how...

H World Group completed a CNY 3.35b offshore senior unsecured bond issue priced at 2.25% and maturing in 2031, with the notes expected to list in Hong Kong and sold to non U.S. investors under Regulation S. The new CNY bonds add fixed rate funding that can support H World Group’s franchise heavy expansion and its recently approved US$2.5b shareholder payout plan. We will look at how H World Group’s investment narrative is reshaped by this low coupon CNY 3.35b bond financing and payout. Scan...

Why the new CFO appointment matters for Fortune Brands Innovations Fortune Brands Innovations (FBIN) has reshaped its finance leadership by appointing Peter G. Clifford as Chief Financial Officer and Executive Vice President. This move places his multi decade background squarely in focus for shareholders. Recent price action has been rough for Fortune Brands Innovations, with the share price down 22.26% year to date and the 1 year total shareholder return declining 25.53%. The modest 1 day...

Exiger, backed by Carlyle Group, Insight Partners, and JMI Equity, has completed an AI-led overhaul of its 1Exiger platform. The company used an AI product lifecycle and proprietary data to compress a planned three year, US$180 million upgrade into a four month, US$20 million build focused on supply chain, procurement, and compliance workflows. This AI-native shift aligns Carlyle Group’s capital with infrastructure that automates code generation and large scale data processing for regulated...

Index removal puts RLX Technology back in focus RLX Technology (NYSE:RLX) has been removed from the FTSE All-World Index (USD), a shift that can affect benchmark-linked flows, investor attention, and how some institutions treat the stock in portfolio construction. Recent trading reflects that shift in attention. RLX Technology has seen its share price return fall 25.86% year to date, while the 1 year total shareholder return is down 29.05%. However, the 3 year total shareholder return remains...

Himax Technologies recently unveiled its HX83196 and HX83197 automotive TDDI chips with integrated high-speed eDP, touch, display driving, eDP 1.4 DSC, HDR10+ and ALS-on-panel support, aimed at large, high-resolution smart car displays. The consolidation of eDP transmission, touch control, display driving and optional local dimming into a single chip targets system complexity, bill of materials and panel maker design flexibility at a time when Himax Technologies faces higher capital...

Revolution Medicines reported that the FDA granted Breakthrough Therapy Designation to RASONQUE in combination with gemcitabine and nab paclitaxel for treatment naïve metastatic pancreatic adenocarcinoma, alongside earlier U.S. approval of RASONQUE for adults who have received prior systemic therapy or are not candidates for multiagent regimens. In the same period, Revolution Medicines was added to the FTSE All World Index, which could affect trading liquidity and raise the profile of its...

The Federal Reserve’s warning that taming inflation could be painful, with higher interest rates and weaker hiring, puts smaller companies under real pressure. Investors are hunting for businesses that already run tight, clean balance sheets instead of relying on cheap money. That is where lower priced, financially disciplined penny stocks come in. This article highlights three such picks from our screener that aim to prioritise financial strength. The three penny stocks highlighted below are...

Gilead Sciences (GILD) has put its HIV prevention push in the spotlight after expanding royalty free lenacapavir licenses to 120 high incidence countries and signing a fresh access agreement with the Pan American Health Organization. These HIV access agreements land at a time when Gilead Sciences’ momentum has been building, with a 90 day share price return of 20.4%, a 1 year total shareholder return of 37.15%, a 3 year total shareholder return above 100%, and a 5 year figure above 150%. Scan...

Willis Lease Finance (WLFC) is drawing fresh attention after buying land in Malaysia to build a new Willis Engine Repair Center, a material expansion of its global maintenance footprint in Asia-Pacific. For investors watching the tape, Willis Lease Finance now trades at US$54.74, with the share price up 22.44% year to date but down about 22% over the past 90 days, and a 5 year total shareholder return of 355.65% hinting at how strongly long term holders have been rewarded even as near term...

Event overview for Dyne Therapeutics stock Dyne Therapeutics (DYN) has drawn fresh attention after announcing plans to present one year clinical data from its Phase 1/2 ACHIEVE trial of zeleciment basivarsen for myotonic dystrophy type 1. The upcoming presentations at the World Muscle Society congress and the AANEM annual meeting will cover functional outcomes, safety findings and matched natural history data, offering investors new insight into the company’s lead investigational...

Kodiak Gas Services (KGS) has agreed to supply 76 megawatts of behind the meter natural gas power for a West Texas data center over six years, with revenue expected from early 2027. Recent trading has been choppy for Kodiak Gas Services, with the share price down 4.24% over the past day and 8.49% over the past month, while still showing a strong year-to-date share price return of 49.42% and a three-year total shareholder return of 268.76%, which points to longer term momentum. Scan for other...

Mettler-Toledo International (MTD) recently drew attention after its share price closed at US$1,430.44. The stock’s move has investors reassessing how recent returns and business results compare with this valuation. Recent trading has been brisk, with a 2.74% 1-day share price return and 11.25% 7-day share price return suggesting fresh interest in Mettler-Toledo International. A 23.67% 90-day share price return contrasts with a more moderate 13.70% 1-year total shareholder return as earlier...

Coca-Cola (KO) slipped 1.13% in the latest session while the broader market advanced, putting extra attention on the stock ahead of its upcoming earnings release and the forecasts tied to that report. Coca-Cola has given investors a mixed ride lately, with the share price slipping 4.37% over the past 30 days but still posting an 8.48% 90-day share price return and a 26.04% year to date share price gain, supported by recent headlines around dividend growth, infrastructure investment and brand...

A blockbuster deal between Paramount, Skydance and Warner Bros Discovery has pushed cinema and studio stocks back into the spotlight, as regulators sign off on a takeover now sized at about $110b. Fresh commitments on theatrical releases and US production spend could reshape how money flows through the big screen ecosystem. This article walks through three US cinema and distribution stocks most exposed to that news and explains why they might matter for your portfolio today. The three stocks...

Jim Cramer’s recent Mad Money spotlight on Hinge Health (HNGE) put the digital musculoskeletal specialist on many watchlists, as investors weigh its rapid expansion against the current price of about $94.45 per share. Hinge Health’s recent TV spotlight comes on top of a powerful run, with the share price up 34.2% over 90 days and a 107.31% year-to-date share price return, while the 1-year total shareholder return of 63.3% points to momentum that has already rewarded existing holders. Scan...

Iovance Biotherapeutics reported record second quarter revenue of nearly US$100 million with a 56% margin, while expanding Amtagvi access toward 110 authorized treatment centers and broader payer coverage targeting more than 250 million lives. The business is also advancing its tumor infiltrating lymphocyte platform into additional solid tumors, as well as next generation TIL and IL-2 programs. This approach could gradually reduce reliance on a single melanoma therapy and support the...

Coca-Cola FEMSA. de has rewarded long term holders with a strong share price run, which naturally raises a question for anyone looking at the stock today. Are the cash flows behind Coca-Cola FEMSA. de enough to support the current valuation, or is the market pricing in something more? Over the past 5 years the stock has returned about 133.7%, which puts real weight on whether that move is backed by the cash Coca-Cola FEMSA. de can generate over time. The business depends heavily on turning...